<DOC>
	<DOCNO>NCT00577538</DOCNO>
	<brief_summary>Patients inflammatory bowel disease ( IBD ) may increase risk lymphoma . The majority lymphoma patient IBD occur area active inflammation . The relationship IBD lymphoproliferative disease however unclear , since chronic inflammation well medication use treat IBD ( especially immunosuppressives - Azathioprine 6-MP - anti-TNF alpha agent ) associate increase risk lymphoma . We plan study association IBD lymphoma large , mixed , community base referral population IBD database Indiana University .</brief_summary>
	<brief_title>Prevalence Lymphoma IBD</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Inflammatory Bowel disease Lymphoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>